-
公开(公告)号：EP1773312B1
公开(公告)日：2014-05-07
申请号：EP05769486.1
申请日：2005-07-19
发明人： CAVAZZA, Claudio
IPC分类号： A61K31/202 , A61K31/366 , A61K31/122 , A61K31/05 , A61K31/045 , A61K31/175 , A61K33/04 , A61K33/30 , A61K47/00 , A61P3/10 , A61P3/04 , A61P3/06 , A61P9/12 , A61P9/00
CPC分类号： A61K45/06 , A61K31/045 , A61K31/05 , A61K31/122 , A61K31/175 , A61K31/202 , A61K31/366 , A61K31/4433 , A61K33/04 , A61K33/30 , A61K2300/00
-
公开(公告)号：EP1255448B1
公开(公告)日：2010-11-17
申请号：EP00985769.9
申请日：2000-11-30
发明人： CAVAZZA, Claudio
CPC分类号： A23C9/13 , A23C9/152 , A23C9/158 , A23C19/0921
摘要： A food selected from the group comprising milk and dairy products derived from milk, comprising a carnitine selected from the group consisting of L-carnitine, acetyl L-carnitine and propionyl L-carnitine in an effective amount to stimulate, through the natural fatty acid metabolic processes that take place in a consumer of said food, the synthesis of polyunsaturated fatty acids from the saturated fatty acids originally contained in the food.
-
23.发明授权COMPOSITION CONSISTING OF PROPIONYL L-CARNITINE AND GLYCINE FOR THE PREVENTION AND/OR TREATMENT OF THE CYTOTOXIC EFFECTS INDUCED BY THE USE OF IMMUNOSUPPRESSIVE AGENTS 有权组合物，包含丙酰基L-肉毒碱和甘氨酸用于预防和/或细胞毒性效应的治疗作为免疫的使用的结果
公开(公告)号：EP1267863B1
公开(公告)日：2006-08-09
申请号：EP01912114.4
申请日：2001-02-20
发明人： CAVAZZA, Claudio
IPC分类号： A61K31/221 , A61K31/198 , A61P39/00
CPC分类号： A61K31/22 , A61K2300/00
摘要： A composition is disclosed which is suitable for the prevention and/or treatment of cell and tissue abnormalities of exogenous, toxic or metabolic origin and suitable for reducing the toxic effects of cyclosporin-A and other immunosuppressive agents, which may take the form of a food supplement or of an actual medicine, containing as its active ingredients in combination or separately packaged: (a) propionyl L-carnitine or one of its pharmacologically acceptable salts, and (b) an amino acid selected from the group consisting of glycine, serine, alanine and arginine, or mixtures thereof.
-
24.发明授权
公开(公告)号：EP1263423B1
公开(公告)日：2006-08-09
申请号：EP01912113.6
申请日：2001-02-20
发明人： CAVAZZA, Claudio
IPC分类号： A61K31/12 , A61K31/221 , A61P7/02 , A61P25/28
CPC分类号： A61K45/06 , A23L33/10 , A23V2002/00 , A61K31/122 , A61K31/205 , A61K2300/00 , A23V2250/0612 , A23V2250/314 , A23V2250/704 , A23V2250/712 , A23V2250/71 , A23V2250/1626 , A23V2250/161 , A23V2250/1642
摘要： A composition is disclosed which is suitable for the prevention and/or treatment of vasculopathic, cardiac, central and peripheral cerebral disturbances and for the prevention of learning disorders or disorders related to ageing, as well as for coping with increased energy requirements, and which may take the form of a dietary supplement or an actual medicine in its own right, containing the following as its characterising active ingredients: (a) propionyl L-carnitine or one of its pharmacologically acceptable salts; and (b) coenzyme Q10.
-
25.发明授权CARNITINE AND INOSITOL PHOSPHATE-CONTAINING COMPOSITION USEFUL AS DIETARY SUPPLEMENT OR DRUG 有权肉毒碱和含成分磷酸肌醇要比饮食额外或药物
公开(公告)号：EP1119363B1
公开(公告)日：2005-07-13
申请号：EP00922866.9
申请日：2000-04-19
发明人： CAVAZZA, Claudio
IPC分类号： A61K31/197 , A61K31/66 , A61P9/00
CPC分类号： A61K31/7024 , A61K31/66 , A61K31/70 , A61K31/205 , A61K2300/00
摘要： A composition is disclosed suitable for the prevention and/or treatment of cardiovascular and neurocerebral disorders, tissue anoxic forms, muscular energy deficits, inflammatory-type abnormalitites, alterations of blood coagulation such as thrombosis, and tissue proliferation forms, that may take the form of a dietary supplement, dietetic support or of an actual medicine, which comprises as characterizing active ingredients: (a) propionyl L-carnitine or a pharmacologically acceptable salt thereof; and (b) an inositol phosphate, particularly the inositol hexaphosphate (IP6).
-
公开(公告)号：EP1001760B1
公开(公告)日：2005-02-02
申请号：EP98929625.6
申请日：1998-06-12
发明人： CAVAZZA, Claudio
IPC分类号： A61K31/205 , A61K31/405
CPC分类号： A61K31/205
摘要： The use of acetyl L-carnitine and its pharmacologically acceptable salts is disclosed for producing a composition suitable for controlling mood disorders mainly in young individuals who are not affected by permanent pathological CNS disturbances.
-
27.发明授权
公开(公告)号：EP1022960B1
公开(公告)日：2002-07-24
申请号：EP98946703.0
申请日：1998-09-18
发明人： FASSI, Aldo , CAVAZZA, Claudio
IPC分类号： A23L1/302 , A23L1/305 , A61K31/205
CPC分类号： A23L33/175 , A23L33/15 , A23V2002/00 , A23V2250/0612
摘要： A combination composition comprising L-carnitine, acetyl L-carnitine and propionyl L-carnitine or the pharmacologically acceptable salts thereof is disclosed which can be used as a pharmaceutical composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics, and as a dietary supplement, health food, medical food or nutraceutical for preventing the abuse of alcohol in substantially healthy subjects, particularly in young individuals.
-
-
-
-
-
-
搜索结果
27 条记录 (耗时 0.021 秒)
